Mitti Jain - Lasa Supergenerics Company Officer
| LASA Stock | 26.58 1.26 4.53% |
Executive
Mitti Jain is Company Officer of Lasa Supergenerics Limited
| Address | Plot no. C-4, Ratnagiri, India, 415722 |
| Phone | 91 96 0797 3801 |
| Web | https://lasalabs.com |
Lasa Supergenerics Management Efficiency
The company has return on total asset (ROA) of (0.0338) % which means that it has lost $0.0338 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2022) %, meaning that it generated substantial loss on money invested by shareholders. Lasa Supergenerics' management efficiency ratios could be used to measure how well Lasa Supergenerics manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Lasa Supergenerics' Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 1.2 B in 2024, whereas Other Assets are likely to drop 855.00 in 2024.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| BE DBM | Hindware Home Innovation | 57 | |
| Salil Kappoor | Hindware Home Innovation | 56 | |
| Sandeep Sikka | Hindware Home Innovation | N/A | |
| Lokesh Gandhi | SIL Investments Limited | 37 | |
| Vikas Baheti | SIL Investments Limited | 43 | |
| Satish Kshirsagar | BF Investment Limited | N/A | |
| Manoj Jain | SIL Investments Limited | N/A | |
| Gayatri Karandikar | BF Investment Limited | N/A | |
| Rajeev MBA | Gokul Refoils and | 52 | |
| Jayeshkumar Thakkar | Gokul Refoils and | 35 | |
| Nitin Malviya | Gokul Refoils and | 42 | |
| Sunil Gupta | Jindal Poly Investment | 60 | |
| Naveen Malik | Hindware Home Innovation | ||
| CA CS | Gokul Refoils and | 45 | |
| Payal Puri | Hindware Home Innovation | N/A | |
| Vinod BCom | Gokul Refoils and | 48 | |
| Swati Tiwari | Jindal Poly Investment | N/A | |
| Yogender Sharma | Rajnandini Metal Limited | N/A | |
| CS CA | Gokul Refoils and | 45 | |
| Sureshkumar Rathod | Gokul Refoils and | 43 | |
| Sakshie Mendiratta | Jindal Poly Investment | 31 | |
Management Performance
| Return On Equity | -0.2 | ||||
| Return On Asset | -0.0338 |
Lasa Supergenerics Leadership Team
Elected by the shareholders, the Lasa Supergenerics' board of directors comprises two types of representatives: Lasa Supergenerics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Lasa. The board's role is to monitor Lasa Supergenerics' management team and ensure that shareholders' interests are well served. Lasa Supergenerics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Lasa Supergenerics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shivanand Hegde, Whole Director | ||
| Varsha Joshi, Chief Officer | ||
| Anil Fargade, Accounts Officer | ||
| Ankita Shetty, Company Officer | ||
| Omkar Herlekar, Chairman MD | ||
| Sunil Sitale, Manager Admin | ||
| Mitti Jain, Company Officer | ||
| Umesh Pawar, Additional Director | ||
| Ravi Kabra, Chief Officer | ||
| Mitti CS, Company Officer |
Lasa Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Lasa Supergenerics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.2 | ||||
| Return On Asset | -0.0338 | ||||
| Profit Margin | (0.19) % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 1.58 B | ||||
| Shares Outstanding | 50.1 M | ||||
| Shares Owned By Insiders | 62.70 % | ||||
| Price To Book | 1.52 X | ||||
| Price To Sales | 1.34 X | ||||
| Revenue | 1.04 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Lasa Stock Analysis
When running Lasa Supergenerics' price analysis, check to measure Lasa Supergenerics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lasa Supergenerics is operating at the current time. Most of Lasa Supergenerics' value examination focuses on studying past and present price action to predict the probability of Lasa Supergenerics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lasa Supergenerics' price. Additionally, you may evaluate how the addition of Lasa Supergenerics to your portfolios can decrease your overall portfolio volatility.